Skip to main content
SpringerLink
Log in

Indikationsstellung und Technik der Brusterhaltenden Operation

  • Chapter
Mammakarzinom

  • 1025 Accesses

Auszug

Die brusterhaltende Therapie (BET) beim Mammakarzinom gilt heute als Standard für die Mehrheit der betroffenen Patientinnen. Durch fortlaufende chirurgische Weiterentwicklungen, einen interdisziplinären Therapieansatz und lokaltherapeutische Qualitätskontrollmaßnahmen im Rahmen wissenschaftlicher Studien konnte die Rate an BET auch im multizentrischen Setting auf bis zu 73% gesteigert werden (Jakesz et al., 2003). An einzelnen hochspezialisierten Behandlungszentren liegt die BET-Rate sogar höher. Damit dieser hohe Standard erreicht und gehalten werden kann, bedarf es der engen koordinierten Zusammenarbeit verschiedener Ab — teilungen und Fachrichtungen. Im Falle der BET sind vor allem die Pathologie, die Radiologie, die internistische Onkologie und die Strahlentherapie als wesentliche Partner zu nennen. Regelmäßige gemeinsame Besprechungen schaffen einen kontinuierlichen Informationsaustausch und den wichtigen persönlichen Kontakt. Die Errungenschaft der BET ist also nicht nur eine Errungenschaft der Chirurgie, sondern vielmehr der immer wichtiger werdenden interdisziplinären Zusammenarbeit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
USD 4.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Al-Ghazal SK, Blamey RW, Stewart J, Morgan AA (1999 a) The cosmetic outcome in early breast cancer treated with breast conservation. Eur J Surg Oncol 25: 566–570

    Article  PubMed  CAS  Google Scholar 

  • Al-Ghazal SK, Fallowfield L, Blamey RW (1999 b) Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 25:571–573

    Article  PubMed  CAS  Google Scholar 

  • Al-Ghazal SK, Fallowfield L, Blamey RW (1999 c) Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol 25:344–346

    Article  PubMed  CAS  Google Scholar 

  • Atkins H, Hayward JL, Klugman DJ, Wayte AB (1972) Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J 2: 423–429

    Article  PubMed  CAS  Google Scholar 

  • della Rovere GQ, Benson JR (2002) Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? Lancet Oncol 3: 183–187

    Article  PubMed  Google Scholar 

  • Delouche G, Bachelot F, Premont M, Kurtz JM (1987) Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 13: 29–34

    PubMed  CAS  Google Scholar 

  • EBCTCG (2002) Radiotherapy for early breast cancer. Cochrane Database Sys Rev 2002(2): CD003647

    Google Scholar 

  • Fisher B, Anderson S, Bryant J et al. (2002 a) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241

    Article  PubMed  Google Scholar 

  • Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002 b) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567–575

    Article  PubMed  Google Scholar 

  • Fitzal F, Krois W, Trischler H, Wutzel L, Kühbelböck U, Wintersteiger B, Riedl O, Jakesz R, Gnant M, Wild T (2207a) The use of a breast symmetry index for objective evaluation of breast cosmesis. The Breast (in press)

    Google Scholar 

  • Fitzal F, Mader N, Rudas M et al. (2007 b) Intra-operative frozen section analyses during breast cancer operations: feasibility and advantages from 1.559 cases. Ann Surg Oncol (under review)

    Google Scholar 

  • Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M (2007c) Breast-conserving surgery for T3/T4 breast cancer: An analysis of 196 patients. Breast Cancer Res Treat (in press)

    Google Scholar 

  • Freedman G, Fowble B, Hanlon A et al. (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005–1015

    Article  PubMed  CAS  Google Scholar 

  • Gnant MFX, Poetter R, Kwasny W et al. (2005) Breast conservation without radiotherapy in low risk breast cancer patients — results of 2 prospective clinical trials of the Austrian Breast and Colorectal Cancer Study Group involving 1,518 postmenopausal patients with endocrine responsive breast cancer. San Antonio Breast Cancer Conference 2005, San Antonio

    Google Scholar 

  • Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–1583

    Article  PubMed  CAS  Google Scholar 

  • Hall-Findlay EJ (1999) A simplified vertical reduction mammaplasty: shortening the learning curve. Plast Reconstr Surg 104: 748–759; discussion 760–763

    Article  PubMed  CAS  Google Scholar 

  • Hengartner MO, Ellis RE, Horvitz HR (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494–499

    Article  PubMed  CAS  Google Scholar 

  • Horst KC, Smitt MC, Goffinet DR, Carlson RW (2005) Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5: 425–438

    PubMed  Google Scholar 

  • Huang E, Buchholz TA, Meric F et al. (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95: 2059–2067

    Article  PubMed  Google Scholar 

  • Jakesz R, Gebhard B, Gnant M, Taucher S (1999) Indications and contraindications for breast preservation in patients with breast cancer. Chirurg 70: 394–399

    Article  PubMed  CAS  Google Scholar 

  • Jakesz R, Hausmaninger H, Kubista E et al. (2002) Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer — Austrian Breast and Colorectal Cancer Study Group Trial 5. J Clin Oncol 20: 4621–4627

    Article  PubMed  CAS  Google Scholar 

  • Jakesz R, Samonigg H, Gnant M et al. (2003) Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast and Colorectal Cancer Study Group. Ann Surg 237: 556–564

    Article  PubMed  Google Scholar 

  • Keynes G (1981) Breast cancer: a case for conservation. Br Med J (Clin Res Ed) 282: 1392

    CAS  Google Scholar 

  • Khanna MM, Mark RJ, Silverstein MJ, Juillard G, Lewinsky B, Giuliano AE (1992) Breast conservation management of breast tumors 4 cm or larger. Arch Surg 127: 1038–1041

    PubMed  CAS  Google Scholar 

  • Komoike Y, Akiyama F, Iino Y et al. (2005) Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12: 104–111

    Article  PubMed  Google Scholar 

  • Kurtz JM, Amalric R, Delouche G, Pierquin B, Roth J, Spitalier JM (1987) The second ten years: long-term risks of breast conservation in early breast cancer. Int J Radiat Oncol Biol Phys 13: 1327–1332

    PubMed  CAS  Google Scholar 

  • Mc Kinnon N (1954) Control of cancer mortality. Lancet 266: 251–254

    Article  PubMed  CAS  Google Scholar 

  • Mustakallio S (1972) Conservative treatment of breast carcinoma-review of 25 years follow up. Clin Radiol 23: 110–116

    Article  PubMed  CAS  Google Scholar 

  • Noh WC, Paik NS, Kim MS et al. (2005) Ipsilateral breast tumor recurrence after breast-conserving therapy: a comparison of quadrantectomy versus lumpectomy at a single institution. World J Surg 29: 1001–1006

    Article  PubMed  Google Scholar 

  • Park WW, Lees JC (1951) The absolute curability of cancer of the breast. Surg Gynecol Obstet 93: 129–152

    PubMed  CAS  Google Scholar 

  • Pezner RD, Patterson MP, Hill LR et al. (1985 a) Breast retraction assessment: an objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys 11: 575–578

    PubMed  CAS  Google Scholar 

  • Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA (1985 b) Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 24: 327–330

    PubMed  CAS  Google Scholar 

  • Recht A, Connolly JL, Schnitt SJ et al. (1986) Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. Semin Oncol 13:434–449

    PubMed  CAS  Google Scholar 

  • Rissanen PM (1969) A comparison of conservative and radical surgery combined with radiotherapy in the treatment of stage I carcinoma of the breast. Br J Radiol 42: 423–426

    PubMed  CAS  Google Scholar 

  • Smitt MC, Nowels KW, Zdeblick MJ et al (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76: 259–267

    Article  PubMed  CAS  Google Scholar 

  • Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S (2005) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241: 629–639

    Article  PubMed  Google Scholar 

  • Thomsen K (1975) Possibilities and limits of breast conserving therapy of carcinoma. Arch Gynakol 219: 99–105

    Article  PubMed  CAS  Google Scholar 

  • Touboul E, Buffat L, Belkacemi Y et al. (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43: 25–38

    PubMed  CAS  Google Scholar 

  • Veronesi U, Banfi A, Del Vecchio M et al. (1986) Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol 22: 1085–1089

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Volterrani F, Luini A et al. (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671–673

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Luini A, Del Vecchio M et al. (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328: 1587–1591

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Luini A, Galimberti V, Zurrida S (1994) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18: 70–75

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Cascinelli N, Mariani L et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227–1232

    Article  PubMed  Google Scholar 

  • Webb SJ, Harrison DJ, Wyllie AH (1997) Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol 41: 1–34

    Article  PubMed  CAS  Google Scholar 

  • Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386–401

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brustambulanz AKH Wien, Universitätsklinik für Chirurgie, Medizinische Universität Wien, Währinger Gürtel 18 - 20, 1090, Wien

    a.o. Univ.-Prof. Dr. F. Fitzal

  2. Universitätsklinik für Chirurgie, Medizinische Universität Wien, Währinger Gürtel 18 - 20, 1090, Wien

    o.Univ. Prof. Dr. M. Gnant (Professor für chirurgisch-experimentelle Onkologie)

Authors
  1. a.o. Univ.-Prof. Dr. F. Fitzal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. o.Univ. Prof. Dr. M. Gnant
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Medizinische Universität Wien, Wien, Österreich

    Raimund Jakesz

  2. Klinische Abteilung für Plastische und Rekonstruktive Chirurgie, Universitätsklinik für Chirurgie, Medizinische Universität Wien, Wien, Österreich

    Manfred Frey

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag / Wien

About this chapter

Cite this chapter

Fitzal, F., Gnant, M. (2007). Indikationsstellung und Technik der Brusterhaltenden Operation. In: Jakesz, R., Frey, M. (eds) Mammakarzinom. Springer, Vienna. https://doi.org/10.1007/978-3-211-29685-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-29685-1_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-29683-7

  • Online ISBN: 978-3-211-29685-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation